We are live on
!
Find out more
KLCMU
Kite Lake Capital Management (UK) Portfolio holdings
AUM
$125M
1-Year Est. Return
198.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.2%
1 Year Est. Return
+198.01%
3 Year Est. Return
+266.95%
5 Year Est. Return
+402.58%
10 Year Est. Return
–
AUM
$346M
AUM Growth
-$3.55M
(-1%)
Cap. Flow
-$16M
Cap. Flow
% of AUM
-4.63%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
4
Increased
4
Reduced
–
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RHT
Red Hat Inc
RHT
|
+$61.5M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$48.8M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$38.3M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
+$24.4M |
| 5 |
Pacific Biosciences
PACB
|
+$6.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$110M |
| 2 |
CELG
Celgene Corp
CELG
|
+$42.2M |
| 3 |
USG
Usg
USG
|
+$24.7M |
| 4 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
+$21.8M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 42.9% |
| 2 | Consumer Discretionary | 21.64% |
| 3 | Healthcare | 17.76% |
| 4 | Materials | 2.95% |
| 5 | Industrials | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RHT
1
DELISTED
Red Hat Inc
RHT
| $148M | 42.9% |
789,782
+333,275
| +73% | +$61.5M |
|
|
WBC
2
DELISTED
WABCO HOLDINGS INC.
WBC
| $74.8M | 21.64% |
564,059
+369,795
| +190% | +$48.8M |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $40.2M | 11.63% |
+867,600
| New | +$24.4M |
|
|
ONCE
4
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $36.3M | 10.5% |
+354,658
| New | +$38.3M |
|
|
5
Pacific Biosciences
PACB
$435M
| $21.2M | 6.13% |
3,503,293
+923,272
| +36% | +$6.47M |
|
6
PUT
Occidental Petroleum
OXY
$55.7B
| $13.3M | 3.86% |
+265,100
| New | +$14.9M |
|
|
VSM
7
DELISTED
Versum Materials, Inc.
VSM
| $10.2M | 2.95% |
197,971
+4,810
| +2% | +$248K |
|
|
FDC
8
DELISTED
First Data Corporation
FDC
| $1.33M | 0.39% |
+49,153
| New | +$1.28M |
|
|
9
Bristol-Myers Squibb
BMY
$129B
| – | – |
-2,335,800
| Closed | -$110M |
|
|
ULTI
10
DELISTED
Ultimate Software Group Inc
ULTI
| – | – |
-38,440
| Closed | -$12.7M |
|
|
USG
11
DELISTED
Usg
USG
| – | – |
-569,554
| Closed | -$24.7M |
|
|
CMTA
12
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| – | – |
-836,070
| Closed | -$21.8M |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| – | – |
-447,200
| Closed | -$42.2M |
|
Similar funds
SWA
AFA
BWLSA
WOSD
PB
CNTOF
SWM
PWP
Kite Lake Capital Management (UK)'s Q2 2019 Portfolio in Review
As of Q2 2019, Kite Lake Capital Management (UK) held 13 positions worth $346M, down 1% from $349M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Kite Lake Capital Management (UK) withdrew a net $16M in Q2 2019, closing 5 positions. Its most notable exit was Bristol-Myers Squibb, an estimated $110M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 43% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Kite Lake Capital Management (UK) opened a new position in Spark Therapeutics, Inc. Common Stock worth $36.3M.
- Kite Lake Capital Management (UK)'s largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 354,658 shares worth $36.3M.
- Kite Lake Capital Management (UK) added most to Red Hat Inc in Q2 2019, an estimated $61.5M increase.
- Kite Lake Capital Management (UK) fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $110M.
- Kite Lake Capital Management (UK)'s ten largest holdings make up 100% of its $346M portfolio in Q2 2019.
- Kite Lake Capital Management (UK) opened 4 new positions and closed 5 in Q2 2019.
- Kite Lake Capital Management (UK)'s portfolio value fell 1% quarter-over-quarter to $346M.
Based on Kite Lake Capital Management (UK)'s 13F filing for Q2 2019, filed 14 Aug 2019.